0001178913-20-000440.txt : 20200213 0001178913-20-000440.hdr.sgml : 20200213 20200213095600 ACCESSION NUMBER: 0001178913-20-000440 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200213 DATE AS OF CHANGE: 20200213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Entera Bio Ltd. CENTRAL INDEX KEY: 0001638097 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-90847 FILM NUMBER: 20607388 BUSINESS ADDRESS: STREET 1: KIRYAT HADASSAH, MINRAV BUILDING STREET 2: FIFTH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 BUSINESS PHONE: 972-2-532-7151 MAIL ADDRESS: STREET 1: KIRYAT HADASSAH, MINRAV BUILDING STREET 2: FIFTH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Capital Point Ltd. CENTRAL INDEX KEY: 0001634113 IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: AZRIELI CENTER, ROUND TOWER 22ND FLOOR CITY: TEL AVIV STATE: L3 ZIP: 67021 BUSINESS PHONE: 972-3-607-0320 MAIL ADDRESS: STREET 1: AZRIELI CENTER, ROUND TOWER 22ND FLOOR CITY: TEL AVIV STATE: L3 ZIP: 67021 SC 13G/A 1 zk2024002.htm SC 13G/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*

Entera Bio Ltd.
(Name of Issuer)

Ordinary Shares, par value NIS 0.0000769 per share
 (Title of Class of Securities)

M40527109
 (CUSIP Number)
 
December 31, 2019
 (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. M40527109
 13G Page 2 of 6 Pages

1
NAME OF REPORTING PERSONS
 
Capital Point Ltd.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP   (See instructions)
(a)  ☐
(b)  ☐
3
SEC USE ONLY
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Israel
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5
SOLE VOTING POWER
 
1,604,820 (*)
6
SHARED VOTING POWER
 
---
7
SOLE DISPOSITIVE POWER
 
1,604,820 (*)
8
SHARED DISPOSITIVE POWER
 
---
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,604,820 (*)
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
 
 ☐
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
8.98% (*) (**)
12
TYPE OF REPORTING PERSON   (See instructions)
 
CO

(*) Comprised of (i) 1,521,520 ordinary shares, and (ii) a warrant to purchase 83,300 ordinary shares.

(**) Based on 17,864,684 ordinary shares outstanding as of December 31, 2019, as provided by the Issuer.
2

Item 1. (a)
Name of Issuer:

Entera Bio Ltd.

             (b)
Address of Issuer's Principal Executive Offices:

Kiryat Hadassah, Minrav Building – Fifth Floor
Jerusalem 9112002, Israel

Item 2. (a)
Name of Person Filing:

Capital Point Ltd.


 (b)
Address of Principal Business Office:

Azrieli 1, Tel Aviv 67021, Israel


 (c)
Citizenship:

Israel


 (d)
Title of Class of Securities:

Ordinary Shares, par value of NIS 0.0000769

(e)
CUSIP Number:

M40527109

Item 3.
Not applicable

Item 4.
Ownership:


(a)
Amount beneficially owned:

   See rows 5-9 of cover page of the reporting person.
3
(b)
Percent of class:

See row 11 of cover page of each reporting person


 (c)
Number of shares as to which such person has:

(i)
Sole power to vote or to direct the vote:

See row 5 of cover page of each reporting person

(ii)
Shared power to vote or to direct the vote:

See row 6 of cover page of each reporting person and note in Item 4(a) above

(iii)
Sole power to dispose or to direct the disposition of:

See row 7 of cover page of each reporting person

(iv)
Shared power to dispose or to direct the disposition of:

See row 8 of cover page of each reporting person and note in Item 4(a) above

Item 5.
Ownership of Five Percent or Less of a Class:

Not applicable

Item 6.
Ownership of More than Five Percent on Behalf of Another:

Not applicable

4
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not applicable

Item 8.
Identification and Classification of Members of the Group:

Not applicable

Item 9.
Notice of Dissolution of Group:

Not applicable

Item 10.
Certification:

Not applicable

5

 SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
February 13, 2020
 
 
Capital Point Ltd.
 
/s/ Shay Lior
By:  Shay Lior
Title: Co-Chief Executive Officer
 
/s/ Yossi Tamar
By: Yossi Tamar
Title: Co-Chief Executive Officer

6